Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Stefano Ruggieri

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Parkinson Disease

Chemicals & Drugs

Living Beings

Anatomy

Concepts & Ideas

Drug Dose-Response Relationship

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Pasquali Livia; Longone Patrizia; Isidoro Ciro; Ruggieri Stefano; Paparelli Antonio; Fornai Francesco
Autophagy, lithium, and amyotrophic lateral sclerosis.
Fornai Francesco; Biagioni Francesca; Fulceri Federica; Murri Luigi; Ruggieri Stefano; Paparelli Antonio
Intermittent Dopaminergic stimulation causes behavioral sensitization in the addicted brain and parkinsonism.
Natale Gianfranco; Kastsiuchenka Olga; Pasquali Livia; Ruggieri Stefano; Paparelli Antonio; Fornai Francesco
MPTP- but not methamphetamine-induced parkinsonism extends to catecholamine neurons in the gut.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Stefano Ruggieri (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Pasquali Livia; Longone Patrizia; Isidoro Ciro; Ruggieri Stefano; Paparelli Antonio; Fornai Francesco
Autophagy, lithium, and amyotrophic lateral sclerosis.
Muscle & nerve 2009;40(2):173-94.
2009: Fornai Francesco; Biagioni Francesca; Fulceri Federica; Murri Luigi; Ruggieri Stefano; Paparelli Antonio
Intermittent Dopaminergic stimulation causes behavioral sensitization in the addicted brain and parkinsonism.
International review of neurobiology 2009;88():371-98.
2008: Natale Gianfranco; Kastsiuchenka Olga; Pasquali Livia; Ruggieri Stefano; Paparelli Antonio; Fornai Francesco
MPTP- but not methamphetamine-induced parkinsonism extends to catecholamine neurons in the gut.
Annals of the New York Academy of Sciences 2008;1139():345-9.
2008: Ruffoli Riccardo; Soldani Paola; Pasquali Livia; Ruggieri Stefano; Paparelli Antonio; Fornai Francesco
Methamphetamine fails to alter the noradrenergic integrity of the heart.
Annals of the New York Academy of Sciences 2008;1139():337-44.
2008: Pasquali Livia; Lazzeri Gloria; Isidoro Ciro; Ruggieri Stefano; Paparelli Antonio; Fornai Francesco
Role of autophagy during methamphetamine neurotoxicity.
Annals of the New York Academy of Sciences 2008;1139():191-6.
2008: Lenzi Paola; Fulceri Federica; Lazzeri Gloria; Casini Alessandro; Ruggieri Stefano; Paparelli Antonio; Fornai Francesco
Analysis of single, purified inclusions as a novel approach to understand methamphetamine neurotoxicity.
Annals of the New York Academy of Sciences 2008;1139():186-90.
2008: Ferrucci Michela; Pasquali Livia; Paparelli Antonio; Ruggieri Stefano; Fornai Francesco
Pathways of methamphetamine toxicity.
Annals of the New York Academy of Sciences 2008;1139():177-85.
2008: Fornai Francesco; Longone Patrizia; Ferrucci Michela; Lenzi Paola; Isidoro Ciro; Ruggieri Stefano; Paparelli Antonio
Autophagy and amyotrophic lateral sclerosis: The multiple roles of lithium.
Autophagy 2008;4(4):527-30.
2008: Fornai Francesco; Siciliano Gabriele; Manca Maria Laura; Murri Luigi; Paparelli Antonio; Ruggieri Stefano
Lithium in ALS: from the bench to the bedside.
Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases 2008;9(2):123-4.
2008: Fornai Francesco; Longone Patrizia; Cafaro Luisa; Kastsiuchenka Olga; Ferrucci Michela; Manca Maria Laura; Lazzeri Gloria; Spalloni Alida; Bellio Natascia; Lenzi Paola; Modugno Nicola; Siciliano Gabriele; Isidoro Ciro; Murri Luigi; Ruggieri Stefano; Paparelli Antonio
Lithium delays progression of amyotrophic lateral sclerosis.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(6):2052-7.
2008: Ferrucci Michela; Pasquali Livia; Ruggieri Stefano; Paparelli Antonio; Fornai Francesco
Alpha-synuclein and autophagy as common steps in neurodegeneration.
Parkinsonism & related disorders 2008;14 Suppl 2():S180-4.
2007: Frenzilli Giada; Ferrucci Michela; Giorgi Filippo Sean; Blandini Fabio; Nigro Marco; Ruggieri Stefano; Murri Luigi; Paparelli Antonio; Fornai Francesco
DNA fragmentation and oxidative stress in the hippocampal formation: a bridge between 3,4-methylenedioxymethamphetamine (ecstasy) intake and long-lasting behavioral alterations.
Behavioural pharmacology 2007;18(5-6):471-81.
2007: Fulceri F; Biagioni F; Ferrucci M; Lazzeri G; Bartalucci A; Galli V; Ruggieri S; Paparelli A; Fornai F
Abnormal involuntary movements (AIMs) following pulsatile dopaminergic stimulation: severe deterioration and morphological correlates following the loss of locus coeruleus neurons.
Brain research 2007;1135(1):219-29.
2007: Fornai Francesco; Lenzi Paola; Lazzeri Gloria; Ferrucci Michela; Fulceri Federica; Giorgi Filippo S; Falleni Alessandra; Ruggieri Stefano; Paparelli Antonio
Fine ultrastructure and biochemistry of PC12 cells: a comparative approach to understand neurotoxicity.
Brain research 2007;1129(1):174-90.
2007: Fornai Francesco; Ruffoli Riccardo; Soldani Paola; Ruggieri Stefano; Paparelli Antonio
The "Parkinsonian heart": from novel vistas to advanced therapeutic approaches in Parkinson's disease.
Current medicinal chemistry 2007;14(23):2421-8.
2007: Fornai Francesco; di Poggio Adolfo Bandettini; Pellegrini Antonio; Ruggieri Stefano; Paparelli Antonio
Noradrenaline in Parkinson's disease: from disease progression to current therapeutics.
Current medicinal chemistry 2007;14(22):2330-4.
2006: Iacovelli Luisa; Fulceri Federica; De Blasi Antonio; Nicoletti Ferdinando; Ruggieri Stefano; Fornai Francesco
The neurotoxicity of amphetamines: bridging drugs of abuse and neurodegenerative disorders.
Experimental neurology 2006;201(1):24-31.
2006: Giorgi Filippo S; Lazzeri Gloria; Natale Gianfranco; Iudice Alfonso; Ruggieri Stefano; Paparelli Antonio; Murri Luigi; Fornai Francesco
MDMA and seizures: a dangerous liaison?
Annals of the New York Academy of Sciences 2006;1074():357-64.
2006: Fulceri Federica; Biagioni Francesca; Lenzi Paola; Falleni Alessandra; Gesi Marco; Ruggieri Stefano; Fornai Francesco
Nigrostriatal damage with 6-OHDA: validation of routinely applied procedures.
Annals of the New York Academy of Sciences 2006;1074():344-8.
2006: Biagioni Francesca; Busceti Carla L; Molinaro Gemma; Battaglia Giuseppe; Giorgi Filippo S; Ruggieri Stefano; Fornai Francesco
Dopamine stimulation via infusion in the lateral ventricle.
Annals of the New York Academy of Sciences 2006;1074():337-43.
2006: Gesi Marco; Lazzeri Gloria; Ferrucci Michela; Pellegrini Antonio; Lenzi Paola; Ruggieri Stefano; Fornai Francesco; Paparelli Antonio
Inclusion dynamics in PC12 is comparable between amphetamines and MPTP.
Annals of the New York Academy of Sciences 2006;1074():315-9.
2006: Lazzeri Gloria; Lenzi Paola; Gesi Marco; Ferrucci Michela; Fulceri Federica; Ruggieri Stefano; Bruno Valeria; Fornai Francesco
In PC12 cells neurotoxicity induced by methamphetamine is related to proteasome inhibition.
Annals of the New York Academy of Sciences 2006;1074():174-7.
2006: Ferrucci Michela; Busceti Carla L; Falleni Alessandra; Giorgi Filippo S; Ruggieri Stefano; Fornai Francesco
Effects of methamphetamine on the cerebellar cortex: a preliminary study.
Annals of the New York Academy of Sciences 2006;1074():149-53.
2006: Fornai Francesco; Lazzeri Gloria; Bandettini Di Poggio Adolfo; Soldani Paola; De Blasi Antonio; Nicoletti Ferdinando; Ruggieri Stefano; Paparelli Antonio
Convergent roles of alpha-synuclein, DA metabolism, and the ubiquitin-proteasome system in nigrostriatal toxicity.
Annals of the New York Academy of Sciences 2006;1074():84-9.
2006: Giorgi Filippo S; Mauceli Giuseppe; Blandini Fabio; Ruggieri Stefano; Paparelli Antonio; Murri Luigi; Fornai Francesco
Locus coeruleus and neuronal plasticity in a model of focal limbic epilepsy.
Epilepsia 2006;47 Suppl 5():21-5.
2006: Giorgi F S; Bandettini di Poggio A; Battaglia G; Pellegrini A; Murri L; Ruggieri S; Paparelli A; Fornai F
A short overview on the role of alpha-synuclein and proteasome in experimental models of Parkinson's disease.
Journal of neural transmission. Supplementum 2006;(70):105-9.
2005: Fornai Francesco; Lenzi Paola; Ferrucci Michela; Lazzeri Gloria; di Poggio Adolfo Bandettini; Natale Gianfranco; Busceti Carla L; Biagioni Francesca; Giusiani Mario; Ruggieri Stefano; Paparelli Antonio
Occurrence of neuronal inclusions combined with increased nigral expression of alpha-synuclein within dopaminergic neurons following treatment with amphetamine derivatives in mice.
Brain research bulletin 2005;65(5):405-13.
2005: Fornai Francesco; Soldani Paola; Lazzeri Gloria; di Poggio Adolfo Bandettini; Biagioni Francesca; Fulceri Federica; Batini Serena; Ruggieri Stefano; Paparelli Antonio
Neuronal inclusions in degenerative disorders Do they represent static features or a key to understand the dynamics of the disease?
Brain research bulletin 2005;65(4):275-90.
2005: Fornai Francesco; Schlüter Oliver M; Lenzi Paola; Gesi Marco; Ruffoli Riccardo; Ferrucci Michela; Lazzeri Gloria; Busceti Carla L; Pontarelli Fabrizio; Battaglia Giuseppe; Pellegrini Antonio; Nicoletti Ferdinando; Ruggieri Stefano; Paparelli Antonio; Südhof Thomas C
Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(9):3413-8.
2004: Fornai F; Gesi M; Lenzi P; Ferrucci M; Lazzeri G; Pizzanelli C; Pellegrini A; Battaglia G; Ruggieri S; Paparelli A
Effects of repeated low doses of MDMA on EEG activity and fluoro-jade B histochemistry.
Annals of the New York Academy of Sciences 2004;1025():181-8.
2004: Fornai F; Lenzi P; Gesi M; Ferrucci M; Lazzeri G; Capobianco L; de Blasi A; Battaglia G; Nicoletti F; Ruggieri S; Paparelli A
Similarities between methamphetamine toxicity and proteasome inhibition.
Annals of the New York Academy of Sciences 2004;1025():162-70.
2004: Monge Alessandra; Viselli Fabio; Stocchi Fabrizio; Barbato Luca; Bolner Andrea; Modugno Nicola; Paradiso Michele; Ruggieri Stefano; Nordera Gianpietro
Variation in the dopaminergic response during the day in Parkinson disease.
Clinical neuropharmacology 2004;27(3):116-8.
2004: Fornai F; Lenzi P; Frenzilli G; Gesi M; Ferrucci M; Lazzeri G; Biagioni F; Nigro M; Falleni A; Giusiani M; Pellegrini A; Blandini F; Ruggieri S; Paparelli A
DNA damage and ubiquitinated neuronal inclusions in the substantia nigra and striatum of mice following MDMA (ecstasy).
Psychopharmacology 2004;173(3-4):353-63.
2003: Fornai F; Lazzeri G; Lenzi P; Gesi M; Ferrucci M; Soldani P; Pellegrini A; Capobianco L; De Blasi A; Ruggieri S; Paparelli A
Amphetamines induce ubiquitin-positive inclusions within striatal cells.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2003;24(3):182-3.
2003: Fornai Francesco; Lenzi Paola; Gesi Marco; Ferrucci Michela; Lazzeri Gloria; Busceti Carla L; Ruffoli Riccardo; Soldani Paola; Ruggieri Stefano; Alessandri Maria G; Paparelli Antonio
Fine structure and biochemical mechanisms underlying nigrostriatal inclusions and cell death after proteasome inhibition.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2003;23(26):8955-66.
2003: Battaglia Giuseppe; Busceti Carla L; Pontarelli Fabrizio; Biagioni Francesca; Fornai Francesco; Paparelli Antonio; Bruno Valeria; Ruggieri Stefano; Nicoletti Ferdinando
Protective role of group-II metabotropic glutamate receptors against nigro-striatal degeneration induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
Neuropharmacology 2003;45(2):155-66.
2003: Fornai F; Lenzi P; Gesi M; Ferrucci M; Lazzeri G; Natale G; Ruggieri S; Paparelli A
Recent knowledge on molecular components of Lewy bodies discloses future therapeutic strategies in Parkinson's disease.
Current drug targets. CNS and neurological disorders 2003;2(3):149-52.
2003: Stocchi Fabrizio; Berardelli Alfredo; Vacca Laura; Barbato Luca; Monge Alessandra; Nordera Giampietro; Ruggieri Stefano
Apomorphine infusion and the long-duration response to levodopa in advanced Parkinson's disease.
Clinical neuropharmacology 2003;26(3):151-5.
2002: Cirone Mara; Cuomo Laura; Zompetta Claudia; Ruggieri Stefano; Frati Luigi; Faggioni Alberto; Ragona Giuseppe
Human herpesvirus 6 and multiple sclerosis: a study of T cell cross-reactivity to viral and myelin basic protein antigens.
Journal of medical virology 2002;68(2):268-72.
2002: Stocchi F; Berardelli A; Vacca L; Thomas A; De Pandis M F; Modugno N; Valente M; Ruggieri S
Combination of two different dopamine agonists in the management of Parkinson's disease.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2002;23 Suppl 2():S115-6.
2002: Ferrucci M; Gesi M; Lenzi P; Soldani P; Ruffoli R; Pellegrini A; Ruggieri S; Paparelli A; Fornai F
Noradrenergic loss enhances MDMA toxicity and induces ubiquitin-positive striatal whorls.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2002;23 Suppl 2():S75-6.
2002: Stocchi Fabrizio; Ruggieri Stefano; Vacca Laura; Olanow C Warren
Prospective randomized trial of lisuride infusion versus oral levodopa in patients with Parkinson's disease.
Brain : a journal of neurology 2002;125(Pt 9):2058-66.
2002: Fornai F; Gesi M; Lenzi P; Ferrucci M; Pellegrini A; Ruggieri S; Casini A; Paparelli A
Striatal postsynaptic ultrastructural alterations following methylenedioxymethamphetamine administration.
Annals of the New York Academy of Sciences 2002;965():381-98.
2002: Battaglia G; Gesi M; Lenzi P; Busceti C L; Soldani P; Orzi F; Rampello L; Nicoletti F; Ruggieri S; Fornai F
Morphological and biochemical evidence that apomorphine rescues striatal dopamine terminals and prevents methamphetamine toxicity.
Annals of the New York Academy of Sciences 2002;965():254-66.
2002: Fornai Francesco; Busceti Carla L; Ferrucci Michela; Lazzeri Gloria; Ruggieri Stefano
Is there a role for uridine and pyrimidine nucleosides in the treatment of vascular dementia?
Functional neurology 2002;17(2):93-9.
2002: Battaglia G; Busceti C L; Cuomo L; Giorgi F S; Orzi F; De Blasi A; Nicoletti F; Ruggieri S; Fornai F
Continuous subcutaneous infusion of apomorphine rescues nigro-striatal dopaminergic terminals following MPTP injection in mice.
Neuropharmacology 2002;42(3):367-73.
2001: Modugno N; Currà A; Giovannelli M; Priori A; Squitieri F; Ruggieri S; Manfredi M; Berardelli A
The prolonged cortical silent period in patients with Huntington's disease.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 2001;112(8):1470-4.
2001: Fornai F; Battaglia G; Gesi M; Orzi F; Nicoletti F; Ruggieri S
Dose-dependent protective effects of apomorphine against methamphetamine-induced nigrostriatal damage.
Brain research 2001;898(1):27-35.
2001: Stocchi F; Vacca L; Berardelli A; De Pandis F; Ruggieri S
Long-duration effect and the postsynaptic compartment: study using a dopamine agonist with a short half-life.
Movement disorders : official journal of the Movement Disorder Society 2001;16(2):301-5.
2001: Stocchi F; Vacca L; De Pandis M F; Barbato L; Valente M; Ruggieri S
Subcutaneous continuous apomorphine infusion in fluctuating patients with Parkinson's disease: long-term results.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2001;22(1):93-4.
2001: Stocchi F; Vacca L; Valente M; Ruggieri S
Sleep disorders in Parkinson's disease.
Advances in neurology 2001;86():289-93.
2001: Caronti B; Antonini G; Calderaro C; Ruggieri S; Palladini G; Pontieri F E; Colosimo C
Dopamine transporter immunoreactivity in peripheral blood lymphocytes in Parkinson's disease.
Journal of neural transmission (Vienna, Austria : 1996) 2001;108(7):803-7.
2000: Fornai F; Battaglia G; Gesi M; Giorgi F S; Orzi F; Nicoletti F; Ruggieri S
Time-course and dose-response study on the effects of chronic L-DOPA administration on striatal dopamine levels and dopamine transporter following MPTP toxicity.
Brain research 2000;887(1):110-7.
2000: Stocchi F; Badiali D; Vacca L; D'Alba L; Bracci F; Ruggieri S; Torti M; Berardelli A; Corazziari E
Anorectal function in multiple system atrophy and Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2000;15(1):71-6.
1999: Caronti B; Tanda G; Colosimo C; Ruggieri S; Calderaro C; Palladini G; Pontieri F E; Di Chiara G
Reduced dopamine in peripheral blood lymphocytes in Parkinson's disease.
Neuroreport 1999;10(14):2907-10.
1999: Stocchi F; Farina C; Nordera G; Ruggieri S
Implantable venous access system for apomorphine infusion in complicated Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1999;14(2):358.
1999: Stocchi F; Corazziari E; Carbone A; Vacca L; De Pandis M F; Berardelli A; Ruggieri S A
Urinary and anorectal function evaluation in Parkinson's disease.
Advances in neurology 1999;80():347-51.
1998: Mercuri B; Berardelli A; Modugno N; Vacca L; Ruggieri S; Manfredi M
Reciprocal inhibition in forearm muscles in patients with essential tremor.
Muscle & nerve 1998;21(6):796-9.
1998: Stocchi F; Barbato L; Nordera G; Berardelli A; Ruggieri S
Sleep disorders in Parkinson's disease.
Journal of neurology 1998;245 Suppl 1():S15-8.
1997: Barbato L; Stocchi F; Monge A; Vacca L; Ruggieri S; Nordera G; Marsden C D
The long-duration action of levodopa may be due to a postsynaptic effect.
Clinical neuropharmacology 1997;20(5):394-401.
1997: Ruggieri S; De Pandis M F; Bonamartini A; Vacca L; Stocchi F
Low dose of clozapine in the treatment of dopaminergic psychosis in Parkinson's disease.
Clinical neuropharmacology 1997;20(3):204-9.
1997: Margotta V; Caronti B; Meco G; Merante A; Ruggieri S; Venturini G; Palladini G
Effects of cocaine treatment on the nervous system of planaria (Dugesia gonocephala s. l.). Histochemical and ultrastructural observations.
European journal of histochemistry : EJH 1997;41(3):223-30.
1996: Stocchi F; Barbato L; Bramante L; Nordera G; Vacca L; Ruggieri S
Fluctuating parkinsonism: a pilot study of single afternoon dose of levodopa methyl ester.
Journal of neurology 1996;243(5):377-80.
1996: Stocchi F; Bonamartini A; Vacca L; Ruggieri S
Motor fluctuations in levodopa treatment: clinical pharmacology.
European neurology 1996;36 Suppl 1():38-42.
1996: Ruggieri S; Fabbrini G; Bramante L; DePandis F; Stocchi F; Barbanti P; Vacca L; Manfredi M
An open study with reversible MAO-A inhibitors in complicated Parkinson's disease.
Advances in neurology 1996;69():595-8.
1996: Stocchi F; Carbone A; Inghilleri M; Frongillo D; Barbato L; Bramante L; Cannata D; Manfredi M; Ruggieri S
Instrumental diagnosis of multiple system atrophy.
Advances in neurology 1996;69():421-4.
1995: Fabbrini G; Baronti F; Ruggieri S; Lenzi G L
Meningioma-induced loss of antiparkinsonian response to levodopa.
Movement disorders : official journal of the Movement Disorder Society 1995;10(2):231-2.
1995: Frongillo D; Stocchi F; Buccolini P; Stecconi P; Viselli F; Ruggieri S; Cannata D
Ambulatory blood pressure monitoring and cardiovascular function tests in multiple system atrophy.
Fundamental & clinical pharmacology 1995;9(2):187-96.
1994: Stocchi F; Barbato L; Bramante L; Bonamartini A; Ruggieri S
The clinical efficacy of a single afternoon dose of levodopa methyl ester: a double-blind cross-over study versus placebo.
Functional neurology 1994;9(5):259-64.
1994: Barbato L; Rinalduzzi S; Laurenti M; Ruggieri S; Accornero N
Color VEPs in Parkinson's disease.
Electroencephalography and clinical neurophysiology 1994;92(2):169-72.
1994: Stocchi F; Quinn N P; Barbato L; Patsalos P N; O'Connel M T; Ruggieri S; Marsden C D
Comparison between a fast and a slow release preparation of levodopa and a combination of the two: a clinical and pharmacokinetic study.
Clinical neuropharmacology 1994;17(1):38-44.
1994: Stocchi F; Patsalos P N; Berardelli A; Barbato L; Bonamartini A; Manfredi M; Ruggieri S
Clinical implications of sustained dopaminergic stimulation.
Clinical neuropharmacology 1994;17 Suppl 2():S7-13.
1993: Capria A; Attanasio A; Frongillo D; Ruggieri S; Stocchi F
Transient left bundle branch block following intravenous lisuride bolus.
Fundamental & clinical pharmacology 1993;7(2):115-7.
1993: Stocchi F; Bramante L; Monge A; Viselli F; Baronti F; Stefano E; Ruggieri S
Apomorphine and lisuride infusion. A comparative chronic study.
Advances in neurology 1993;60():653-5.
1993: Stocchi F; Barbato L; Carbone A; Fabbrini G; Ruggieri S; Bonamartini A; Baffigo G; Agnoli A
Urodynamic study in the differential diagnosis between multiple system atrophy and Parkinson's disease.
Advances in neurology 1993;60():434-7.
1992: Steiger M J; Stocchi F; Bramante L; Ruggieri S; Quinn N P
The clinical efficacy of single morning doses of levodopa methyl ester: dispersible Madopar and Sinemet plus in Parkinson disease.
Clinical neuropharmacology 1992;15(6):501-4.
1992: Stocchi F; Ruggieri S; Carta A; Ryatt J; Quinn N; Jenner P; Marsden C D; Agnoli A
Intravenous boluses and continuous infusions of L-dopa methyl ester in fluctuating patients with Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1992;7(3):249-56.
1991: Formisano R; Ruggieri S; Cerbo R; Lucarelli F; De Vuono G; Parmegiani M; Agnoli A; Attanasio A; Capria A; Piccolo C G
Continuous intravenous infusion of TRH-T: clinical, cardiovascular and endocrinological effects.
Acta neurologica Scandinavica 1991;84(6):514-8.
1991: Baronti F; Ruggieri S; Mouradian M M; Bonamartini A; Bocciarelli P; De Pandis M F; Chase T N; Agnoli A
[Changes in the nigrostriatal dopamine receptor compartment after continuous dopaminergic infusions in Parkinson disease]
Rivista di neurologia 1991;61(6):210-4.
1991: Ruggieri S; Stocchi F; Baronti F; Viselli F; Horowski R; Lucarelli C; Agnoli A
Antagonist effect of terguride in Parkinson's disease.
Clinical neuropharmacology 1991;14(5):450-6.
1991: Steiger M J; Stocchi F; Carta A; Ruggieri S; Agnoli A; Quinn N P; Marsden C D
The clinical efficacy of oral levodopa methyl ester solution in reversing afternoon "off" periods in Parkinson's disease.
Clinical neuropharmacology 1991;14(3):241-4.
1990: Attanasio A; Capria A; Leggiadro G; Michisanti M; Cannata D; Stocchi F; Ruggieri S
Transient cardiac arrest during continuous intravenous infusion of apomorphine.
Lancet 1990;336(8726):1321.
1989: Venturini G; Stocchi F; Margotta V; Ruggieri S; Bravi D; Bellantuono P; Palladini G
A pharmacological study of dopaminergic receptors in planaria.
Neuropharmacology 1989;28(12):1377-82.
1989: Capria A; Attanasio A; Quatrana M; Cannata D; Fioravanti M; Stocchi F; Ruggieri S
Cardiovascular effects of lisuride continuous intravenous infusion in fluctuating Parkinson's disease.
Clinical neuropharmacology 1989;12(4):331-8.
1989: Ruggieri S; Stocchi F; Carta A; Bragoni M; Agostini C; Barbato L; Agnoli A
One year treatment with lisuride delivery pump in Parkinson's disease.
Progress in neuro-psychopharmacology & biological psychiatry 1989;13(1-2):173-83.
1988: Ruggieri S; Carta A; Stocchi F; Antonini A; Bellantuono P; Monge A
Pharmacological strategies for controlling motor fluctuations in Parkinson's disease.
Functional neurology 1988;3(4):471-9.
1988: Agnoli A; Stocchi F; Carta A; Antonini A; Bragoni M; Ruggieri S A
Continuous dopaminergic stimulation in the management of complicated Parkinson's disease.
The Mount Sinai journal of medicine, New York 1988;55(1):62-6.
1988: Ruggieri S; Stocchi F; Carta A; Bravi D; Bragoni M; Giorgi L; Agnoli A
Comparison between L-dopa and lisuride intravenous infusions: a clinical study.
Movement disorders : official journal of the Movement Disorder Society 1988;3(4):313-9.
1988: Stocchi F; Ruggieri S; Antonini A; Baronti F; Brughitta G; Bellantuono P; Bravi D; Agnoli A
Subcutaneous lisuride infusion in Parkinson's disease: clinical results using different modes of administration.
Journal of neural transmission. Supplementum 1988;27():27-33.
1987: Stocchi F; Ruggieri S; Baronti F; Bellantuono P; Brughita G; Antonini A; Bravi D; Agnoli A
[On-off phenomena in Parkinson's disease. Continuous dopaminergic stimulation]
La Clinica terapeutica 1987;122(2):83-8.
1987: Capria A; Stocchi F; Attanasio A; Quatrana M; Cannata D; Ruggieri S
Unusual cardiovascular response to intravenous lisuride bolus. Possible drug-induced coronary angiospasm.
Chest 1987;91(5):792-3.
1987: Berardelli A; Stocchi F; Gallucci M; Ruggieri S; Accornero N; Agnoli A; Manfredi M
Neurophysiological and magnetic resonance studies in a patient with hemiballismus.
Functional neurology 1987;2(1):93-8.
1986: Ruggieri S; Denaro A; Meco G; Carta A; Stocchi F; Agnoli A
Multicenter trial of L-Deprenyl in Parkinson disease.
Italian journal of neurological sciences 1986;7(1):133-7.
1986: Stocchi F; Ruggieri S; Brughitta G; Agnoli A
Problems in daily motor performances in Parkinson's disease: the continuous dopaminergic stimulation.
Journal of neural transmission. Supplementum 1986;22():209-18.
1986: Ruggieri S; Stocchi F; Denaro A; Baronti F; Agnoli A
The role of MAO-b inhibitors in the treatment of Parkinson's disease.
Journal of neural transmission. Supplementum 1986;22():227-33.
1984: Agnoli A; Ruggieri S; Meco G; Casacchia M; Denaro A; Conti L; Bedini L; Stocchi F; Fioravanti M; Franzese A
An appraisal of the problem of dementia in Parkinson's disease.
Advances in neurology 1984;40():299-306.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Stefano Ruggieri

Research Profile (preview)

Disorders

Chemicals & Drugs

Living Beings

Anatomy

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Stefano Ruggieri (preview)

All Publications